The World Osteoporosis Day was celebrated last Friday. Osteoporosis is a disease where complex and complicated molecular pathways interact to reduce bone and mineral density. This results in the medical condition where bones become brittle and weak.
India ranks number one in the total number of Osteoporosis cases. According to doctors, around 61 million elders in India have osteoporosis, among which 80 percent are women. Worldwide, more than 200 million people are suffering from osteoporosis.
The rising prevalence of bone and joint issues, the increased desire for minimally invasive and non-invasive operations, and the growing geriatric population are driving the market for bone growth stimulators.
A bone growth stimulator activates a series of receptors in the body that release chemicals to progress fracture healing. Its best advantage is that it accelerates the entire process of bone healing, resulting in faster recovery, shorter hospitalization, higher cost-effectiveness, and fewer infections.
Because of an aging population and rapid economic expansion, the bone growth stimulators market in numerous Asia-Pacific countries is likely to grow rapidly over the next decade. Among them, India is predicted to be the fastest-growing market with a CAGR of 11.4%.
The growth will be fueled primarily by improvements in the country’s healthcare landscape. As of now, only 20 percent of the osteoporosis cases are getting diagnosed. Worldwide, 1 in 3 women over the age of 50 years and 1 in 5 men experience osteoporotic fractures in their lifetime.